Cargando…
In Vivo Sustained Release of Peptide Vaccine Mediated by Dendritic Mesoporous Silica Nanocarriers
Mesoporous silica nanoparticles have drawn increasing attention as promising candidates in vaccine delivery. Previous studies evaluating silica-based vaccine delivery systems concentrated largely on macromolecular antigens, such as inactivated whole viruses. In this study, we synthesized dendritic m...
Autores principales: | An, Weiteng, Defaus, Sira, Andreu, David, Rivera-Gil, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244784/ https://www.ncbi.nlm.nih.gov/pubmed/34220835 http://dx.doi.org/10.3389/fimmu.2021.684612 |
Ejemplares similares
-
Quaternized Chitosan-Capped Mesoporous Silica Nanoparticles as Nanocarriers for Controlled Pesticide Release
por: Cao, Lidong, et al.
Publicado: (2016) -
Disrupting GPCR Complexes with Smart Drug-like Peptides
por: Gallo, Maria, et al.
Publicado: (2022) -
pH-Responsive Release of Ruthenium Metallotherapeutics from Mesoporous Silica-Based Nanocarriers
por: Mladenović, Minja, et al.
Publicado: (2021) -
Applications and Biocompatibility of Mesoporous Silica Nanocarriers in the Field of Medicine
por: Zhang, Chengcheng, et al.
Publicado: (2022) -
Hitchhiking with Nature: Snake Venom Peptides to Fight Cancer and Superbugs
por: Pérez-Peinado, Clara, et al.
Publicado: (2020)